Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Daiichi Sankyo
Moodys
Baxter
Chinese Patent Office
Mallinckrodt
Covington
Johnson and Johnson
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,267,179

« Back to Dashboard

Summary for Patent: 4,267,179
Title: Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidaz oles and 1H-1,2,4-triazoles
Abstract:Novel heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazol es and 1H-1,2,4-triazoles, useful as antifungal and antibacterial agents.
Inventor(s): Heeres; Jan (Vosselaar, BE), Backx; Leo J. J. (Arendonk, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:06/020,383
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 4,267,179

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,267,179

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 5140 ➤ Subscribe
Austria 5479 ➤ Subscribe
Australia 4816079 ➤ Subscribe
Australia 528095 ➤ Subscribe
Bosnia and Herzegovina 96067 ➤ Subscribe
Bulgaria 50387 ➤ Subscribe
Bulgaria 60430 ➤ Subscribe
Canada 1149386 ➤ Subscribe
Czechoslovakia 241468 ➤ Subscribe
Czechoslovakia 7904087 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Fuji
Harvard Business School
Teva
Mallinckrodt
Citi
Healthtrust
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot